We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Inpeco

Inpeco is a global leader in automation systems for clinical laboratories and designs cutting-edge solutions for both... read more Featured Products: More products

Download Mobile App





Inpeco Launches Next-Generation Total Lab Automation System

By LabMedica International staff writers
Posted on 01 Aug 2024

At ADLM 2024, Inpeco SA (Novazzano, Switzerland) is introducing FlexLab X, its new total lab automation system, to the global laboratory medicine community. More...

Set to redefine automation excellence, FlexLab X offers enhanced flexibility, a best-in-class user experience, and excellent performance. Open and flexible by design, FlexLab X allows labs to freely combine analyzers from different vendors, for optimal patient outcomes. Its standardized track components enable space-saving layouts tailored to a lab’s needs that scale easily in three dimensions, to support future growth. Offering sleek graphical user interfaces (GUI) and powerful Data Analytics functionalities, FlexLab X is intuitively easy to use and monitor. This simplifies daily work and helps eliminate errors, while KPI dashboards provide actionable insights to streamline workflows.

Thanks to its outstanding performance, FlexLab X assures rapid and consistent turnaround times (TAT) at all sample volume levels, and it supports premium-quality results that are fully traceable. Moreover, FlexLab X is designed to maximize uptime and reduce running costs, contributing to an attractive return on investment (ROI). Clinical laboratories benefit from safe and efficient workflows that get the daily routine done. Premium-quality results support improved patient outcomes, and the attractive return delivered by a FlexLab X investment helps labs to better cope with increasing budget pressures.

Related Links:
Inpeco SA


Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: New findings indicate that chimeric RNAs, once viewed as cancer byproducts, can also be part of normal physiology with regulatory functions (Image credit: Adobe Stock)

Female-Specific RNA Biomarker May Help Explain Sex Differences in Immune Disease

Women show distinct susceptibility to infectious diseases and higher rates of autoimmune disorders, yet the molecular drivers remain unclear. This gap has limited sex-specific diagnostic and prognostic tools.... Read more

Microbiology

view channel
Image: Multidrug-resistant Klebsiella pneumoniae is a growing community health concern, causing recurrent UTIs in older adults and complicating first-line antibiotic treatment (Image Credit: Adobe Stock)

Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella

Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more

Industry

view channel
Image: The proposed immunoassay uses ALZpath’s pTau217 antibody to detect Alzheimer’s disease biology in blood, supporting the growing role of blood-based biomarkers in clinical care (Photo courtesy of Shutterstock)

Agreement Supports pTau217-Based Alzheimer’s Blood Test Development

As disease-modifying therapies for Alzheimer’s disease expand, accessible diagnostics are increasingly needed to identify patients earlier. Current confirmatory methods, including PET imaging and cerebrospinal... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.